190 related articles for article (PubMed ID: 18252959)
1. Plasma membrane expression of GnRH receptors: regulation by antagonists in breast, prostate, and gonadotrope cell lines.
Finch AR; Sedgley KR; Caunt CJ; McArdle CA
J Endocrinol; 2008 Feb; 196(2):353-67. PubMed ID: 18252959
[TBL] [Abstract][Full Text] [Related]
2. Plasma membrane expression of gonadotropin-releasing hormone receptors: regulation by peptide and nonpeptide antagonists.
Finch AR; Caunt CJ; Armstrong SP; McArdle CA
Mol Endocrinol; 2010 Feb; 24(2):423-35. PubMed ID: 20009083
[TBL] [Abstract][Full Text] [Related]
3. Intracellular gonadotropin-releasing hormone receptors in breast cancer and gonadotrope lineage cells.
Sedgley KR; Finch AR; Caunt CJ; McArdle CA
J Endocrinol; 2006 Dec; 191(3):625-36. PubMed ID: 17170220
[TBL] [Abstract][Full Text] [Related]
4. Agonist-induced internalization and downregulation of gonadotropin-releasing hormone receptors.
Finch AR; Caunt CJ; Armstrong SP; McArdle CA
Am J Physiol Cell Physiol; 2009 Sep; 297(3):C591-600. PubMed ID: 19587220
[TBL] [Abstract][Full Text] [Related]
5. Arrestin-mediated ERK activation by gonadotropin-releasing hormone receptors: receptor-specific activation mechanisms and compartmentalization.
Caunt CJ; Finch AR; Sedgley KR; Oakley L; Luttrell LM; McArdle CA
J Biol Chem; 2006 Feb; 281(5):2701-10. PubMed ID: 16314413
[TBL] [Abstract][Full Text] [Related]
6. Dominant-negative action of disease-causing gonadotropin-releasing hormone receptor (GnRHR) mutants: a trait that potentially coevolved with decreased plasma membrane expression of GnRHR in humans.
Leaños-Miranda A; Ulloa-Aguirre A; Ji TH; Janovick JA; Conn PM
J Clin Endocrinol Metab; 2003 Jul; 88(7):3360-7. PubMed ID: 12843188
[TBL] [Abstract][Full Text] [Related]
7. Pharmacoperone IN3 enhances the apoptotic effect of leuprolide in prostate cancer cells by increasing the gonadotropin-releasing hormone receptor in the cell membrane.
Sánchez CA; Mercado AJ; Contreras HR; Cabezas JC; Huidobro CC; Castellón EA
Anticancer Drugs; 2012 Oct; 23(9):959-69. PubMed ID: 22713594
[TBL] [Abstract][Full Text] [Related]
8. Human loss-of-function gonadotropin-releasing hormone receptor mutants retain wild-type receptors in the endoplasmic reticulum: molecular basis of the dominant-negative effect.
Brothers SP; Cornea A; Janovick JA; Conn PM
Mol Endocrinol; 2004 Jul; 18(7):1787-97. PubMed ID: 15105440
[TBL] [Abstract][Full Text] [Related]
9. Regulation of G protein-coupled receptor trafficking by inefficient plasma membrane expression: molecular basis of an evolved strategy.
Janovick JA; Knollman PE; Brothers SP; Ayala-Yáñez R; Aziz AS; Conn PM
J Biol Chem; 2006 Mar; 281(13):8417-25. PubMed ID: 16446355
[TBL] [Abstract][Full Text] [Related]
10. GnRH-II analogs for selective activation and inhibition of non-mammalian and type-II mammalian GnRH receptors.
Maiti K; Li JH; Wang AF; Acharjee S; Kim WP; Im WB; Kwon HB; Seong JY
Mol Cells; 2003 Oct; 16(2):173-9. PubMed ID: 14651258
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone (GnRH) receptors of cattle aggregate on the surface of gonadotrophs and are increased by elevated GnRH concentrations.
Kadokawa H; Pandey K; Nahar A; Nakamura U; Rudolf FO
Anim Reprod Sci; 2014 Nov; 150(3-4):84-95. PubMed ID: 25301533
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional down-regulation of human gonadotropin-releasing hormone (GnRH) receptor gene by GnRH: role of protein kinase C and activating protein 1.
Cheng KW; Ngan ES; Kang SK; Chow BK; Leung PC
Endocrinology; 2000 Oct; 141(10):3611-22. PubMed ID: 11014215
[TBL] [Abstract][Full Text] [Related]
13. Differential signaling of the GnRH receptor in pituitary gonadotrope cell lines and prostate cancer cell lines.
Sviridonov L; Dobkin-Bekman M; Shterntal B; Przedecki F; Formishell L; Kravchook S; Rahamim-Ben Navi L; Bar-Lev TH; Kazanietz MG; Yao Z; Seger R; Naor Z
Mol Cell Endocrinol; 2013 Apr; 369(1-2):107-18. PubMed ID: 23380421
[TBL] [Abstract][Full Text] [Related]
14. Evolved regulation of gonadotropin-releasing hormone receptor cell surface expression.
Janovick JA; Ulloa-Aguirre A; Conn PM
Endocrine; 2003 Dec; 22(3):317-27. PubMed ID: 14709805
[TBL] [Abstract][Full Text] [Related]
15. Signalling and anti-proliferative effects mediated by gonadotrophin-releasing hormone receptors after expression in prostate cancer cells using recombinant adenovirus.
Franklin J; Hislop J; Flynn A; McArdle CA
J Endocrinol; 2003 Feb; 176(2):275-84. PubMed ID: 12553876
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone receptor-mediated growth suppression of immortalized LbetaT2 gonadotrope and stable HEK293 cell lines.
Miles LE; Hanyaloglu AC; Dromey JR; Pfleger KD; Eidne KA
Endocrinology; 2004 Jan; 145(1):194-204. PubMed ID: 14551223
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of hypogonadotropic hypogonadism: restoration of mutant (E(90)K) GnRH receptor function by a deletion at a distant site.
Maya-Núñez G; Janovick JA; Ulloa-Aguirre A; Söderlund D; Conn PM; Méndez JP
J Clin Endocrinol Metab; 2002 May; 87(5):2144-9. PubMed ID: 11994356
[TBL] [Abstract][Full Text] [Related]
18. Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines.
Pályi I; Vincze B; Kálnay A; Turi G; Mezõ I; Teplán I; Seprõdi J; Pató J; Móra M
Cancer Detect Prev; 1996; 20(2):146-52. PubMed ID: 8706040
[TBL] [Abstract][Full Text] [Related]
19. Internalization of gonadotropin-releasing hormone receptors (GnRHRs): does arrestin binding to the C-terminal tail target GnRHRs for dynamin-dependent internalization?
Hislop JN; Caunt CJ; Sedgley KR; Kelly E; Mundell S; Green LD; McArdle CA
J Mol Endocrinol; 2005 Aug; 35(1):177-89. PubMed ID: 16087731
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone receptor concentration differentially regulates intracellular signaling pathways in GGH3 cells.
Pinter JH; Janovick JA; Conn PM
Pituitary; 1999 Nov; 2(3):181-90. PubMed ID: 11081152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
